Tuberc Respir Dis.  2019 Jan;82(1):1-5. 10.4046/trd.2017.0101.

Smoking Cessation Strategies Targeting Specific Populations

• Chun EM

• KMID: 2441724
• DOI: http://doi.org/10.4046/trd.2017.0101

Abstract

Quitting smoking helps smokers maintain their health and extend their lifespan by 10 or more years. Treatment strategies for smoking cessation should be tailored to individual smokers with special needs based on their specific circumstances. It is recommended that pregnant women adopt smoking cessation through counseling and behavioral interventions because the safety of medications has yet to be established. Counseling is the main strategy for smoking cessation in adolescents and nicotine replacement therapy can be used with caution in individuals with serious nicotine dependence. It is important for smokers with psychiatric diseases to quit smoking following accurate assessment of their depression status. Nicotine replacement therapy, varenicline, and bupropion can be used for smoking cessation in smokers with psychiatric disorders. The incidence of cardiovascular disease decreased according to the smoking status and the duration of smoking cessation. In smokers with chronic obstructive pulmonary disease (COPD) who used a combination of counseling and pharmacotherapy the quitting rate was more than twice as high as subjects who used behavioral interventions alone. Varenicline can be used as the most effective anti-smoking drug by most smokers including those with psychiatric disorders, cardiovascular disease, and COPD.

Keyword

Smoking Cessation; Population; Pharmacotherapy

MeSH Terms

Adolescent
Bupropion
Cardiovascular Diseases
Counseling
Depression
Drug Therapy
Female
Humans
Incidence
Nicotine
Pregnant Women
Pulmonary Disease, Chronic Obstructive
Smoke*
Smoking Cessation*
Smoking*
Tobacco Use Disorder
Varenicline
Bupropion
Nicotine
Smoke
Varenicline

Reference

1. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013; 368:341–350. PMID: 23343063.

2. Foulds J, Schmelzer AC, Steinberg MB. Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease. Int J Clin Pract. 2010; 64:142–146. PMID: 19919548.

3. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008; (2):CD000165. PMID: 18425860.

4. Korea Centers for Disease Control and Prevention. The sixth Korea National Health and Nutrition Examination Survey, 2015 [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2015. cited 2017 Dec 10. Available from: http://knhanes.cdc.go.kr.

5. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health Study. Am J Obstet Gynecol. 1990; 163(1 Pt 2):285–291. PMID: 2142573.

6. Siu AL. U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015; 163:622–634. PMID: 26389730.

7. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2012; (9):CD010078. PMID: 22972148.

8. Chamberlain C, O'Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2017; 2:CD001055. PMID: 28196405.

9. Peirson L, Ali MU, Kenny M, Raina P, Sherifali D. Interventions for prevention and treatment of tobacco smoking in school-aged children and adolescents: a systematic review and meta-analysis. Prev Med. 2016; 85:20–31. PMID: 26743631.

10. Stanton A, Grimshaw G. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2013; (8):CD003289. PMID: 23975659.

11. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. JAMA. 1990; 264:1546–1549. PMID: 2395194.

12. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet. 1995; 25:95–101. PMID: 7733862.

13. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction. 2010; 105:1176–1189. PMID: 20491721.

14. Weiner E, Buchholz A, Coffay A, Liu F, McMahon RP, Buchanan RW, et al. Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study. Schizophr Res. 2011; 129:94–95. PMID: 21376537.

15. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013; (2):CD007253. PMID: 23450574.

16. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016; 387:2507–2520. PMID: 27116918.

17. van Eerd EA, van der Meer RM, van Schayck OC, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016; (8):CD010744. PMID: 27545342.

18. Kotz D, Viechtbauer W, Simpson CR, van Schayck OC, West R, Sheikh A. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease. Thorax. 2017; 72:905–911. PMID: 28473506.

19. Tottenborg SS, Thomsen RW, Johnsen SP, Nielsen H, Lange P. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest. 2016; 150:554–562. PMID: 27262226.

20. Clair C, Rigotti NA, Porneala B, Fox CS, D'Agostino RB, Pencina MJ, et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013; 309:1014–1021. PMID: 23483176.

21. Suissa K, Lariviere J, Eisenberg MJ, Eberg M, Gore GC, Grad R, et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2017; 10:e002458. PMID: 28093398.